Brief: China Nt Pharma obtains certification from China Food and Drug Administration
03/03/2017 04:17
March 3 (Reuters) - China Nt Pharma Group Co Ltd 1011.HK :
* Jiangsu NT Biopharma successfully obtained new good
manufacturing practices certification from China Food and Drug
Administration
* Estimated that production line can commence production of
"Xi Di Ke" in March and sales will officially commence in April
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7ZK0wm
Further company coverage: 1011.HK
((Bangalore.newsroom@thomsonreuters.com))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY